$ADTX

Takeover Time 2026 LLC sold $68K of ADTX

Takeover Time 2026 LLC sold 3,420,439 shares of Aditxt, Inc. (ADTX) at $0.02 on 2026-06-23.

Original reporting
SEC EDGAR · Takeover Time 2026 LLC
Published Jun 25, 2026, 11:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ADTX
Bearish
medium confidence
Mentioned
$ADTX
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ADTXBearishLow
01

Why it matters

The disclosed open-market sale reduces the insider’s stake to zero and may influence short-term sentiment, though it does not provide new operating/financial information.

02

Market read

Traders may reassess near-term order-flow risk after a large insider position is fully liquidated, but fundamentals remain unchanged in the text.

03

What to watch

No 10b5-1 plan is cited, but the sale date (2026-06-23) suggests the decision may have been made earlier; without context on other holdings, signal strength is limited.

Relevance 3/10Novelty 4/10Timing: After-hours/filing impact: SEC Form 4 filed 2026-06-25 for a sale dated 2026-06-23.

Background

The article summarizes an SEC Form 4 insider transaction for Aditxt, Inc. (ADTX) by a 10% owner.

Company-level read

Ticker impact

$ADTXBearishMedium confidence
Context

A 10% owner (Takeover Time 2026 LLC) sold 3,420,439 ADTX shares at $0.0200/share in an SEC Form 4 filed June 25.

Expected impact

Likely modest downward pressure or heightened volatility around the filing/next sessions, absent other catalysts.

Evidence & confidence

The filing is primary-source and time-stamped, but the transaction is an open-market sale with no 10b5-1 plan and no accompanying company news.

Market effects

Limited read-across: this is company-specific insider selling, not a sector-wide regulatory/clinical catalyst.

Minimal; no cross-market linkage is described.

None indicated; the disclosure is confined to ADTX ownership/transactions.

Counterpoint

The seller exited the position (0 shares after), which could reflect diversification/liquidity needs rather than a bearish view on ADTX fundamentals.

Key entities

  • Aditxt, Inc.

    Issuer of the securities; subject of the Form 4 insider sale disclosure.

  • Takeover Time 2026 LLC

    10% owner who sold 3,420,439 ADTX shares at $0.0200/share.

Related articles